Federal Register Notice: CBER is inviting participants for its Regulatory Site Visit Training Program. It is intended to give CBER regulatory review, compliance, and other relevant staff an opportunity to visit biologics facilities. These visits are intended to allow CBER staff to directly observe routine manufacturing practices and to give CBER staff a better understanding of the biologics industry, including its challenges and operations. To view this notice, click here.